A Phase 2 Study of JTT-851

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221688

Enrollment

420

Registered

2012-01-12

Start date

2012-01-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

investigational material(s) Generic name etc : JTT-851 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : O

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A historical diagnosis of type 2 diabetes mellitus A glycosylated hemoglobin level between 7.0% and 10.0%

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c (12weeks)	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026